Good morning, and thank you for joining Lincoln Financial Group's First Quarter 2019 Earnings Conference Call. [Operator Instructions]. Now I'd like to turn the conference over to the Corporate Treasurer, Chris Giovanni. Please go ahead, sir.

Thank you, Crystal. Good morning, and welcome to Lincoln Financial's First Quarter Earnings Call. Before we begin, I have an important reminder. Any comments made during the call regarding future expectations, trends and market conditions, including comments about sales and deposits, expenses, income from operations, share repurchases and liquidity and capital resources are forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from current expectations. These risks and uncertainties include those described in the cautionary statement disclosures in our earnings release issued yesterday as well as those detailed in our 2018 annual report on Form 10-K, most recent quarterly report on Form 10-Q and from time to time in our other filings with the SEC. These forward-looking statements are made only as of today, and we undertake no obligation to update or revise any of them to reflect events or circumstances that occur after this date. We appreciate your participation today and invite you to visit Lincoln's website, www.lincolnfinancial.com, where you can find our press release and statistical supplement, which include a full reconciliation of the non-GAAP measures used in the call, including adjusted income from operations and adjusted return on equity to their most comparable GAAP measures. I would also like to remind you that we will be hosting our Investor Day on June 12 in New York City, and we hope many of you will join us in person. Presenting on today's call are Dennis Glass, President and Chief Executive Officer; and Randy Freitag, Chief Financial Officer and Head of Individual Life. After their prepared remarks, we will move to the question-and-answer portion of the call. I would now like to turn the call over to Dennis.

Thank you, Chris, and good morning, everyone. We had a strong start to the year and momentum is building into the second quarter as we effectively execute on key management initiatives. In the first quarter, all four business segments grew operating revenues. We had very strong sales growth and 9% increase in both adjusted operating earnings per share and book value per share, excluding AOCI. Our strength in sales was broad-based and highlights actions taken to maximize our diverse product portfolio in attractive fast-growing segments of the market and leverage our powerful distribution franchise, a competitive advantage for Lincoln, to drive profitable top line growth. Notably, the near-term sales outlooks remains encouraging. Most of our businesses also saw expense ratios improve as we continue to focus on expense efficiency through process redesign and expanding digital capabilities. We also deployed over $300 million of capital through buybacks and dividends during the quarter and are well positioned to continue to fund new business growth at attractive returns while remaining committed to consistently returning capital to shareholders. Now turning to our business segments, starting with annuities. Operating income of $250 million decreased from the prior year quarter predominantly from the impact of the Athene transaction. Our strategic decision to broaden the product portfolio and participate in more segments of the marketplace enabled another quarter of robust and diversified sales as we continue to reach additional advisers and customers. This resulted in sales increasing 39% to $3.5 billion with net inflows of nearly $0.5 billion while continuing to achieve our profitability targets. Fixed annuity sales momentum continued as we benefited from shelf space expansion and increase in bank wholesalers and some customized FIA products. Sales of $1.6 billion more than tripled over the prior year quarter as every distribution channel generated sales gains, including…

Thank you, Dennis. First quarter reflects many of the themes that we have exhibited for nearly a decade. Strong top line performance with all 4 business showing revenue growth and total operating revenues up nearly 20% over the prior year quarter, boosted by last year's acquisition. Expense discipline as expense ratios improved in 3 of our 4 businesses and a strong balance sheet with book value per share, excluding AOCI growing 9%, allowing us to reduce our average diluted share count by 7%. Bringing together these items drove adjusted operating income of $441 million or $2.14 per share for the quarter, a 9% increase from the prior year and a 12.6% adjusted operating return on equity. There were no notable items within the current or prior year quarter. However, there were a few items that resulted in some variability within the businesses. The net impact of these items was 0, and I will speak to some of these within the business segments. Net income totaled $252 million in the quarter as we experienced more below the line volatility than we have historically reported. Importantly, the vast majority of the difference between our adjusted operating income and net income was the result of $143 million in items we would consider to be noneconomic with the impact primarily coming from the Athene transaction, where changes in fair value for most of the asset portfolio run through the balance sheet while the offsetting change runs through the income statement. Over time, this noneconomic impact will reverse and subside. Excluding the noneconomic impacts, net income represented 90% of adjusted operating income as the VA hedge program performed well, credit losses were minimal and acquisition and integration expenses were consistent with our expectations. Now turning to segment results, starting with annuities. Reported operating income for…

Thank you, Dennis and Randy. We will now begin the question-and-answer portion of the call. [Operator Instructions]. With that, let me turn the call back to the operator.

[Operator Instructions]. Our first question comes from Suneet Kamath from Citi.

Just wanted to start with RPS in the large case termination that you had talked about. Any color on what drove that? Was it M&A or pricing? And then just thoughts on overall competition in the RPS market.

Yes. Suneet, you mentioned it. That was an outcome of an acquisition or a merger. And oftentimes, not always, the acquiring company who had a different provider than the acquired company will win in that situation. So that's what it was, M&A and our customer, the smaller client and we lost the business. Now we did bid on it, but we couldn't match the other pricing. Overall, competitive environment. I guess I'd come back to where we participate first. We're active in the small case 401(k) market. We focus on education, government markets and healthcare. We have good market positions in those cases. Competition and pricing is tough, but we think with what we bring to the table with our strategy, we can continue to do very well.

Got it. And then just pivoting over to Group Protection. We've been hearing a lot about voluntary benefits. Some companies talking about price competition there, particularly in certain lines. So can you give us some color in terms of what you're seeing in terms of new business, particularly on the voluntary side?

Yes. I think I would answer the question a little more broadly. We think the pricing in both employee paid and voluntary is rational. We don't see any irrational pricing, to say it the other way. So we'll continue to do well in both those markets. The Liberty acquisition gives us an opportunity to increase employee sales because they had less of that in their mix. So it's a big opportunity for us going forward.

And our next question comes from Ryan Krueger from KBW.

Could you give a sense of how meaningfully VA sales improved during the quarter as market normalize?

Yes. Let me talk in terms of the percentage of sales. So back in January, we were selling fixed annuities and variable annuities at about 50-50. The mix was 50-50. By the end of April, that has switched from 50-50 to 2/3 variable annuity sales and 1/3 fixed annuity sales. And so that's the trend that we expect to continue and they're up overall so far total sales.

Got it. And then on -- in Group Protection, expenses look to improve a fair amount. Randy, could you just give a sense of, I guess, where you are at this point relative to your expense save guidance?

Sure, Ryan. If you remember, we talked about exiting 2018 at a run rate of 75 and expecting to exit 2019 at a run rate of roughly 100 and then adding to that in 2020 and beyond. I'd say we're at a run rate now of roughly 80, right on track to get to our goal of a run rate of 100 by the end of the year. I think the group business did have a really good quarter from an expense management standpoint and executing on the synergies which we talked about. I think there may have been a little bit of timing in their expenses, but nothing that I would consider to be really out of line with outside of just good overall expense management and execution.

And our next question comes from Elyse Greenspan from Wells Fargo.

My first question is on the annuities business. You did obviously had stronger sales in fixed and VA in the quarter, but you did mention strong sales momentum and you'll get some additional fee days in subsequent quarters. So what I'm trying to -- the outlook seems better overall for sales in that business than when you announced the Athene transaction. So I'm wondering if you will be able to earn back the earnings that you lost from that reinsurance block deals sooner than you might have expected? Can you just update us on some thoughts there?

When we did the deal, we always anticipated that we'd replace the sold liabilities in a 24-month period or so, maybe 36 months. And because of the increasing results that we've seen, better than what we had anticipated, that might come back a little bit quicker.

Okay. Can you quantify that or just want to wait and see?

It's difficult to quantify because as you saw last year -- or excuse me, last quarter, the split between fixed annuities and variable annuities was different than it is today. Some of that is consumer preference. Some of that is capital market impacts decision for consumer and the financial advisers are recommending. But let me just say we don't think that -- obviously differently, we will replace that income in a reasonable amount of time.

Okay. And then my second question on the group business. Did the late flu season benefit your results in the quarter? Just some color there will be great.

Elyse, thanks for the question. I think as I noted, our very strong loss ratio in the quarter featured lower incidents in the disability side and then a little higher claim severity on the Life side. I don't think that was specifically related to the nature of the flu season. I think it's just overall consistent with what we typically or oftentimes we'll see in the first quarter. I don't think there was anything outstanding about the flu season and its impact on our group business.

And our next question comes from Tom Gallagher from Evercore.

First question, just on the net income volatility you saw this quarter, and I think you referenced that was related to the reinsurance transaction. Can you comment whether you would expect that to remain higher level of volatility going forward? Or should we expect that to come down over time?

Tom, thanks for the question. I think as I said at the end of my paragraph on that particular topic, I said we expect it to reverse and subside. So the amount we had in the first quarter, which was $94 million associated with that transaction, that will reverse and it should subside. Why will it subside? It will subside as Athene repositions the asset portfolio. The size of it just had to do with the change in interest rates in the first quarter and the amount of the assets that still remain in an available for sale classification, which give -- gave you a fairly large change, a positive change in the unrealized gain. That positive change in the unrealized gain which runs through our balance sheet, we don't own the economics of that business, so obviously that has to get reversed out. Where it gets reversed out is through net income. It's -- I've asked a number of accountants about this. It's both noneconomic and bad accounting, but that's just the reality. And as I said, it will reverse and subside.

Got you. And Randy, that's GAAP only, not statutory, correct?

Correct.

Okay. Just on the mortality experience. I think in 4Q, Individual Life had some adverse experience and it looks like you pretty much recovered all of that and then some with the favorable in 1Q. And I think -- if I'm correct, I think what you're essentially normalizing to now seems to be somewhat higher level than I recall for 1Q. Is that a fair observation? And also, can you talk a bit about how you see Individual Life playing out throughout the balance of the year? And the reason I'm asking is I -- at least my -- the way I was perceiving your Individual Life results last year was pretty favorable. But if I'm taking your 1Q run rate, maybe you're assuming some continued favorability or continued similar level of margins that you had last year. But anyway, sorry for the long-winded question, but any thoughts there.

No problem, Tom. We are very happy with the first quarter. As I mentioned, it was $25 million last year in the first quarter. That was roughly $5 million. Now that's relative to our expectations. And as I've talked about before, we do have seasonality in our mortality -- in our Individual Life mortality expectations. That seasonality at a high level is typically 110% in the first quarter, 100% in the second quarter and roughly 95% and 95% in the third and fourth quarter. So that's how the seasonality typically plays out in our business. Now of course, we've got a big business and can move around inside those longer-term expectations. So with that 110% expectation in the first quarter, we did better than that. We did better than that to the tune of $25 million, as I mentioned. I don't think it changes our longer-term expectations on mortality. As I've said before, if you look back over the 8 years, you can -- every year, we're within 1% of 100, either above or below or exactly at 100 with the exception of 1 year, which I was at the caveat, which was 2015 when we had a bad second quarter, my recollection is. So nothing has changed about our longer-term expectations. The one thing we know is that we will have volatility quarter-to-quarter. But when you look over longer periods of time like a year, you tend to find a strong reversion to that mean of 100%.

Our next question comes from Jimmy Bhullar from JP Morgan.

So first for Randy, just on spreads. In both the annuity and retirement businesses, your spreads have been down even if we exclude alternate investment income. So just any comments on what your expectations are? And to the extent that you can quantify where your new money yield stand with the drop in interest rates recently or so far this year versus where the sort of yields are on the bonds that are going off the books? And when do you expect the spread compression to abate?

Jimmy, I think if you look at those two businesses and the annuity business, there is no spread pressure. We have plenty of flexibility to manage spreads. You will see quarter-to-quarter volatility. But over time, you will see a strong consistency to our annuity spreads. In fact, if you look year-over-year, we're at 1.56% this year. This is excluding variable investment income versus 1.55% last year, so very consistent with our longer-term expectations. In the Retirement business, we were down 12 basis points year-over-year as I noted in my script. We have a guidance out there of 10 to 15, so we're at the lower end of that. I think looking forward, we would expect that number to continue to decline over the next couple of years before it eventually disappears. I think in terms of the new money yields, as Dennis mentioned, I think we're at 4.40% in the quarter. And Dennis, if you have anything there to add?

So we're at 4.40% in the quarter. Rates dropped off a little bit, Jimmy, so that might be lower as we speak today. Fixed income book yield is 4.65%. We will go into greater detail at the investor conference around the issue of what's rolling off, what the new investment rate is and when we expect to see spread compression completely abate.

And if I remember correctly, I think you have a lot of higher yielding securities that are maturing this year, right? So beyond this year, the impact of spread compression, assuming stable interest rates, abates a little bit purely for that reason.

You're exactly right, Jimmy.

And then just one more on the variable annuity business. You mentioned you expect an improvement in sales in 2Q. Seasonally, Q2 tends to be stronger for the industry overall. But are there other reasons for you sounding optimistic on sales-related decline a decent amount on a sequential basis.

Are you talking about individual annuity sales or just variables?

Yes, variable annuity sales.

Yes. Variable annuity sales, again, for some reason, the mix between fixed and variable in the last quarter was different than it is in April and we've seen that mix change going forward. So same comments that we've been making. Our index variable annuity is continuing to gain traction with both new distribution partners and then bringing financial advisers in. So that would create a spike, and we're adding in our other product lines additional distribution. I mentioned in the fixed annuity line, we've added some IMOs and provided some customized products. So it's really very much us taking advantage of the strength of our distribution, participating in segments of the annuity market, both fixed annuity that we hadn't been in before. And that's why we think over the next couple of years, we can drive better total annuity growth than what the industry averages would be.

And our next question comes from Humphrey Lee from Dowling & Partners.

Just to follow-up on annuity sales. You've talked about, in April, the mix is 2/3 VA, 1/3 fixed annuities. That's the, I think, the mix that you're expecting going forward. But I guess from a longer-term perspective, is that the desirable mix that you would like to pursue for your annuity business?

Yes. Humphrey, that's a very good question. And when you ask that question, there's a lot of considerations. So -- and let me just say, as between fixed annuities and variable annuities, you have to manage ROA because they're different for both. You have to manage ROE because they're different for both. And then as we've discussed over the long term, we have managed the balance of long- and short-term liabilities. So all of those considerations go into where we're putting our efforts. To some extent, the market is going to determine what the gross sales of the 2 products are. But within our system with -- the strength of our distribution permits us to migrate, to some extent, the sales to the categories that we want them in to maximize ROA -- ROE and achieve our balance of short term -- short- and long-term liabilities.

I appreciate the deeper color. And then a question for Randy. In Group Protection, I was just wondering can you talk about the progress of the repricing efforts that you have on the Liberty block? And how should we think about that going forward as we progress?

Yes. I think I'll take that one, and let me just start to say -- the comment by saying we're well ahead of expectations on this. Let me give you some specifics on that. We had to reprice about $1.8 billion in premiums. We have already repriced $1.4 billion in premiums. On the repricing of that $1.4 billion, we had about 7% increase in rate on the business that stayed, and we've got an improvement including both the improvement from the lower margins on what left plus the higher margins on what stayed of about 7%. So that when you do the math on all of that, we picked up about $70 million of earnings from the repricing already. Some of that is showed up in 2018. The balance will show up in 2019 and 2020. We have the $400 million left to reprice. We expect we'll still get sort of similar results on that. The other comment I would make is that at the time of the presentation of the Liberty merger, we indicated that it would take 2-, 3-year cycles to get all of the pricing that we needed. Actually, we're pleased because what repricing started before, Lincoln was involved, was very helpful. And now we think at the end of this first cycle, we're essentially done on repricing.

And our next question comes from John Nadel from UBS.

Randy, I guess, first question. I'll start with a comment. I think we all really appreciate the simplicity of the earnings and the lack of notable items, I guess, on a consolidated basis that's the case. I guess I just -- I'd ask for your help maybe a little bit more in terms of quantifying the larger offsetting items. I mean I think, obviously, variable investment income or alternative investment income was low. Mortality was favorable. There were some DAC items and maybe a little bit of tax rate. I guess I'll just ask for your help in quantifying some of these larger items that netted zero.

No problem, John. As I mentioned in my script, as we see them, they add up to 0. So what are those items that add up to zero? Items in the Life business included, as I mentioned, $25 million of favorable mortality in Life and then $15 million of favorable amortization expenses, which just has to do with experience coming in better than our assumptions in the model. So that's $40 million on the positive side of the ledger. On the negative side, you have the lower alt returns, which across the entire organization was $29 million. $21 million of that occurs in the Life business and the another $8 million is primarily in retirement and annuity with a little bit in group. Additionally, you have the $11 million of elevated group DAC amortization, $40 million positives, $40 million of negatives, you get back to 0. I think there have been some questions. I was reading some of the notes on the tax rate. I don't really see much there, so let me go over that. When tax reform was enacted, we guided to a 15% to 17% range. I think as you look at last year, so the full year 2018, we came in right at 15%, so the very low end of that range. And inside of that full year, what you will see is that, all else being equal, the first quarter, we'll have our lowest effective tax rate. Why will it ever lowest effective tax rate? It's because the tax preference items are largely at level over the year, whereas the pretax income is typically lowest in the first quarter because of a lot of the seasonal items I've talked about. Higher Individual Life mortality, fewer fee days, and the annuity in the retirement business, et cetera, et cetera. So we feel like last year, we had 13.9% effective tax rate in the first quarter. This year, we're at 13%. That small difference, I would attribute it we had a small amount of DRD true-up 3 million spread across three businesses. And I would note that there were other small items, I think, that went against that and then you had a little bit of other benefit, but very small numbers. Did that help, John?

I understand your point. Absolutely. Yes, it is helpful, Randy. And then I understand the accounting that has this sort of geography differential between your AOCI and the realized gain/loss impact on the Athene coinsured portfolio or reinsured portfolio. But I guess what I'm having trouble understanding is why -- what's going to -- what is actually going to cause that to reverse. Mechanically, what -- when is that going to happen? And what does that?

Sure. So as I mentioned, it comes about because a significant amount of the portfolio, which we transferred to Athene, is still classified as available for sale, which -- and which unrealized gains and losses run through the balance sheet and there was an unrealized gain in the first quarter. Now we can't have the economics of that because we don't own the business anymore, so there's this offsetting entry. So what can cause it to reverse? There are a number of things. If the unrealized gain went back down in the next quarter, that would be one way you would get the opposite impact. If the assets were held until maturity, of course, the unrealized gain would drift away. And over time, you would see the offsetting entries or if and when Athene repositions the asset portfolio. Because when they do reposition, that available for sale asset becomes a trading asset. And of course, with the trading asset, the changes in value run through the income statement just like the offsetting entry. So did that help, John?

Yes. That's hopeful. And I've got one last quick one. It's just looking at the $1.6 billion of fixed and indexed annuity deposits in the quarter, is there really any true fixed deferred annuities in there? Is that almost entirely or entirely fixed indexed annuities? And is all of that under the coinsurance arrangement with Athene?

Yes. So if you talk about SPIAs and in that one category -- it's about $180 million. The rest is in fixed rate, fixed index about $1.4 billion. And of that $1.4 billion, I think that there's about $600 million -- $500 million associated in the quarter with the Athene transaction.

Our next question comes from John Barnidge from Sandler O'Neill.

Apologies if I missed it, but on prior calls you talked about evaluating block transaction for the life and annuity book to free up capital. Is that something you're continuing to do?

Yes. We look at every opportunity to advance shareholder value. And so those kinds of ideas remain under analysis. Whether or not they would mature into a transaction, we won't comment one way or the other.

Okay. And then my follow-up. Sales across the border are strong. Is it your opinion that rumors of the economy's slowdown have been greatly exaggerated? Or is there anything you're seeing that gives you pause either in the distribution channel, customer demand or anything else?

I'll leave predicting the growth of the economy to the experts. I will say though that it's [indiscernible] from the insurance business, what's more important is the flow of wealth and the change in who's getting the wealth. And we'll show some statistics on this at our investor meeting. There's a lot of people going into the cohorts that we sell to, a lot of wealth coming out of retirement plans and going into the hands of the cohorts of age that we sell to. So I think that drives our long-term opportunities more so than the ebb and flow of GDP.

Our next question comes from Erik Bass from Autonomous Research.

How much further scope do you see to expand distributions for annuities or life products? And do you see any other potential opportunities similar to what you're able to do with Allstate? Or are there other large distributors where you're not on the shelf currently?

Well, in the annuity business, the only PNC company that we are now selling with is Allstate, so there'd be opportunities there. I think we have the opportunity to penetrate further in the annuity business on just about every channel that we participate in. We're talking some -- to some additional banks at the moment. So I think there's more opportunity in places where we are not to get more sales. And when you go over to the individual business, and Randy can speak to this, but we ought to have -- we're the major player in Life Insurance in the United States other than the mutual companies. And so we should have a significant segment of every -- we have a significant share of every segment, and we typically do, except in the individual -- excuse me, in IUL marketplace or 17th out of 20, I think. So there is an example where -- and that happens to be the biggest market for Life Insurance sales in the United States. And Randy is going to correct me if I misspeak here, but there's an opportunity to really increase our position. We've introduced a new product and an example of the kind of things that we're trying to do. And Randy, I'm sorry I'm speaking on your behalf.

No. I don't disagree. Erik, thanks for the question. I think on the Life side, it's more a function of products and markets that we may not be fully participating. And so I'll give you a couple of examples, because there's a connection somewhat to distribution in there, term insurance. We're a little underrepresented in the aggregator space. And Will and his team are doing a great job of getting us onto some of those platforms. We're a little underrepresented in the smaller faced term market, and we're doing things like with the TermAccel product to be better represented. That all came together and really strong Term sales growth in the first quarter. As Dennis mentioned, we are also underrepresented in the indexed UL space, and we did come out with a couple of products in February to improve that position. And I think that will -- with those products, which represent an improvement. From a competitive standpoint, that should give us access to some markets and distribution channels where those products are sold. But broadly speaking, Dennis is absolutely correct. With the size of our life business, the broadness of our product portfolio, we have a pretty strong representation among the people who sell Life Insurance.

And then questions on group persistency. If you can comment on trends there. And I know you called out in group that amortization was a bit higher. And is that due to lapses? Or is it more just kind of reissue activity where you're -- there's no sort of impact on the forward earnings of the business?

Yes. Our combined block persistency is holding pretty steady. It's may be down a little bit first quarter, but not anything to worry about. And Randy, I'll turn over the question on this -- the...

I couldn't agree more. I think, absolutely, our overall persistency is right in line with our expectations. Inside of there, there are some subsegments where you may have had a little worst persistency, for example. We have an old voluntary book arising from the old Lincoln portfolio where persistency was a little worse than expected. And that drove actually some of the higher-than-expected DAC amortization. But overall, I think persistency continues to run right in line with our expectations. And we, in fact, have not seen the shock lapses that we priced into the Liberty deal.

Our next question comes from Andrew Kligerman from Crédit Suisse.

Just kind of following up on the group. You had a pretax -- an after-tax margin of 4.8% versus the guided 5% to 7%. And if I took the midpoint of that 5% to 7%, that would imply close to $50 million of additional earnings pickup probably due to the repricing and the expense savings on the Liberty acquisition. So I think, Randy, you mentioned another $20-or-so million coming on the expense side. I think Dennis was talking a little bit about continued benefits from repricing. So should I assume that repricing and the expenses just get another $50 million in pickup over the course of the next year? Or is there more than that? Do we get closer to the 7%?

Andrew, I believe that what you are using in your denominator is total revenues. And when we talk about margins, what we use in our denominator is premiums. So the margin in the first quarter -- which is an industry standard, by the way. The margin in the first quarter was 5.4%. I think as both Dennis and I have said, we expect over the long term to be between 5% and 7%. But given our improved scale, given the synergies that we've come in, we expect we can move to the upper half of that range. So another 1% would be another $10 million of earnings a quarter or so, so...

Okay. So maybe another 40-ish to go. That's helpful. And then I know there was a lot of talk on the call about yields and so forth, but maybe you can help me just a little bit with the trajectory in the annuity business, which is the biggest spread area. You went from a yield of 3.99% to 4.02%. You went from a crediting rate, and I suspect this is due to the Athene transaction of 2.31% to 2.41%. So the spread shrank by 7 basis points. And I'm just kind of wondering where -- I think, Randy, you said that there's no spread pressure. You expect it to be consistent. Where should I be expecting the spread to go? And maybe you could give a little trajectory on the yield and the credited interest.

Andrew, I have a phrase where I say the latest is the greatest. And so I think I wouldn't move too far from what we reported in the quarter, which was 1.56% and -- which as I mentioned earlier, was very level with the year ago quarter. So I'm going to stick with my, the latest is the greatest.

And our next question comes from Alex Scott from Goldman Sachs.

So I wanted to ask you about the FASB changes that are coming in, and I know it's probably still far too early to talk about specific book value transition impact and specific volatility. But I guess, just knowing investors have sort of appreciated Lincoln's simpler sort of reporting structure, consistency of earnings, et cetera. When you think about that volatility that we sort of know is on the horizon, what are the levers that you're looking at that are sort of on the table to maybe put you in a better position as you get closer to that, whether it's uses of reinsurance, different hedging strategies, different product structures? Any color you can provide.

Alex, I think we're too far off to give you any specifics within aside. I appreciate your comment that investors appreciate our consistency of results. That's absolutely been what we've shown over the years. I wish it was reflected a little better in the valuation of the company at as an aside, I think, Alex, you are going to see us use all the levers, everything we have at our disposal to manage our way through the implementation of the accounting guidance. And I think when we get through it, well, yes, there may be a little noise. We're still working on getting there. I think you will see a similar Lincoln to what you have seen in the past, which is a company, which has high quality results, returns and consistency above our peers. And that's our expectations, and we will use all the tools we have at our disposal to get there.

And that does conclude our question-and-answer session for today's conference. If there is any one left with any questions, the company will be able to follow-up with you later in the afternoon. And at this time, I would like to turn the conference back over to Chris Giovanni for any closing remarks.

Thank you, Crystal, and thank you all for joining us this morning. As always, we'll take your questions on our Investor Relations line at 800-237-2920 or via e-mail at investorrelations@lfg.com. Thank you all, and have a great day.

Ladies and gentlemen, thank you for participating in today's conference. This does conclude the program, and you may all disconnect. Everyone, have a wonderful day. Speakers, please standby.